 Christopher Evans
Concepts (471)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucins | 22 | 2024 | 69 | 4.090 |
Why?
| | Mucus | 14 | 2024 | 57 | 3.620 |
Why?
| | Mucin-5B | 23 | 2024 | 184 | 2.860 |
Why?
| | Mucin 5AC | 17 | 2024 | 47 | 2.290 |
Why?
| | Lung | 36 | 2021 | 3865 | 2.080 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 43 | 1.950 |
Why?
| | Respiratory Mucosa | 17 | 2024 | 264 | 1.710 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 54 | 1.710 |
Why?
| | Idiopathic Pulmonary Fibrosis | 12 | 2022 | 467 | 1.400 |
Why?
| | Expectorants | 4 | 2023 | 23 | 1.270 |
Why?
| | Asthma | 9 | 2024 | 2150 | 1.140 |
Why?
| | Bronchial Hyperreactivity | 5 | 2015 | 92 | 0.990 |
Why?
| | Vagus Nerve | 4 | 2023 | 82 | 0.940 |
Why?
| | Bronchioles | 4 | 2024 | 23 | 0.890 |
Why?
| | Quantum Dots | 3 | 2012 | 34 | 0.870 |
Why?
| | Animals | 62 | 2024 | 34345 | 0.840 |
Why?
| | Reflex | 1 | 2023 | 70 | 0.840 |
Why?
| | Respiratory System | 6 | 2020 | 145 | 0.830 |
Why?
| | Mice | 43 | 2024 | 15984 | 0.780 |
Why?
| | Disulfides | 2 | 2022 | 92 | 0.770 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 67 | 0.740 |
Why?
| | Homeostasis | 6 | 2020 | 605 | 0.730 |
Why?
| | Alveolar Epithelial Cells | 2 | 2019 | 98 | 0.720 |
Why?
| | Lung Injury | 2 | 2021 | 213 | 0.660 |
Why?
| | Eosinophilia | 1 | 2020 | 185 | 0.600 |
Why?
| | Disease Models, Animal | 17 | 2022 | 3823 | 0.600 |
Why?
| | Mice, Transgenic | 14 | 2020 | 2061 | 0.600 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 5102 | 0.590 |
Why?
| | Hypersensitivity | 1 | 2021 | 265 | 0.580 |
Why?
| | Epithelial Cells | 10 | 2019 | 1005 | 0.550 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 87 | 0.540 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 20 | 0.530 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 9 | 2022 | 1347 | 0.530 |
Why?
| | Selenium Compounds | 2 | 2012 | 21 | 0.520 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.520 |
Why?
| | Cadmium Compounds | 2 | 2012 | 29 | 0.510 |
Why?
| | Pulmonary Alveoli | 3 | 2016 | 399 | 0.500 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 476 | 0.480 |
Why?
| | Macrophages | 3 | 2016 | 1333 | 0.470 |
Why?
| | Inflammation | 11 | 2022 | 2612 | 0.440 |
Why?
| | Lung Diseases | 2 | 2018 | 768 | 0.440 |
Why?
| | Eosinophils | 4 | 2021 | 273 | 0.430 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2244 | 0.430 |
Why?
| | Cadmium | 1 | 2012 | 62 | 0.410 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 990 | 0.410 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1233 | 0.400 |
Why?
| | Surface-Active Agents | 1 | 2012 | 82 | 0.400 |
Why?
| | Immunity, Innate | 5 | 2019 | 759 | 0.390 |
Why?
| | Intracellular Space | 1 | 2012 | 72 | 0.390 |
Why?
| | Uteroglobin | 5 | 2010 | 17 | 0.380 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1195 | 0.380 |
Why?
| | Ribonucleases | 3 | 2000 | 55 | 0.370 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 16 | 0.360 |
Why?
| | Transcription Factors | 1 | 2018 | 1604 | 0.360 |
Why?
| | Bronchi | 3 | 2016 | 259 | 0.350 |
Why?
| | Cilia | 4 | 2022 | 166 | 0.350 |
Why?
| | Exocytosis | 3 | 2019 | 91 | 0.340 |
Why?
| | Mucous Membrane | 4 | 2021 | 123 | 0.310 |
Why?
| | Humans | 45 | 2024 | 125131 | 0.310 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 543 | 0.310 |
Why?
| | Airway Obstruction | 2 | 2016 | 187 | 0.300 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 836 | 0.280 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 84 | 0.270 |
Why?
| | Ovalbumin | 7 | 2015 | 168 | 0.270 |
Why?
| | Munc18 Proteins | 2 | 2019 | 23 | 0.270 |
Why?
| | Gene Expression | 4 | 2018 | 1528 | 0.250 |
Why?
| | Colloids | 3 | 2019 | 60 | 0.240 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 471 | 0.240 |
Why?
| | Phagocytosis | 3 | 2016 | 364 | 0.240 |
Why?
| | Mice, Knockout | 12 | 2019 | 2736 | 0.230 |
Why?
| | Th2 Cells | 4 | 2017 | 167 | 0.230 |
Why?
| | Energy Metabolism | 2 | 2024 | 786 | 0.220 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 632 | 0.220 |
Why?
| | Female | 31 | 2021 | 64889 | 0.220 |
Why?
| | Salts | 1 | 2023 | 41 | 0.210 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2492 | 0.210 |
Why?
| | Glycosyltransferases | 1 | 2022 | 13 | 0.210 |
Why?
| | Glycolysis | 1 | 2024 | 241 | 0.210 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 12 | 0.210 |
Why?
| | Bronchiectasis | 1 | 2024 | 112 | 0.210 |
Why?
| | MicroRNAs | 3 | 2019 | 660 | 0.210 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.210 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 8 | 0.210 |
Why?
| | Glycoproteins | 2 | 2022 | 330 | 0.210 |
Why?
| | Golgi Apparatus | 1 | 2022 | 96 | 0.200 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 53 | 0.200 |
Why?
| | Colon | 2 | 2022 | 243 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2382 | 0.200 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1743 | 0.190 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 361 | 0.190 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 24 | 0.190 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 191 | 0.190 |
Why?
| | Metaplasia | 5 | 2008 | 59 | 0.190 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 192 | 0.180 |
Why?
| | Substance P | 1 | 2000 | 44 | 0.180 |
Why?
| | Leukocyte Count | 1 | 2021 | 315 | 0.180 |
Why?
| | Blood Proteins | 3 | 2000 | 253 | 0.170 |
Why?
| | Mustard Gas | 1 | 2021 | 119 | 0.170 |
Why?
| | Antigens | 4 | 2007 | 324 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 127 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2019 | 30 | 0.170 |
Why?
| | Fibroblasts | 1 | 2024 | 859 | 0.170 |
Why?
| | Allergens | 2 | 2015 | 430 | 0.170 |
Why?
| | Hypoxia | 2 | 2017 | 1021 | 0.170 |
Why?
| | Male | 22 | 2021 | 60792 | 0.170 |
Why?
| | Gene Targeting | 2 | 2018 | 84 | 0.170 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 80 | 0.170 |
Why?
| | Butadienes | 2 | 2009 | 34 | 0.170 |
Why?
| | Polystyrenes | 2 | 2009 | 34 | 0.160 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 56 | 0.160 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 108 | 0.160 |
Why?
| | Interleukin-13 | 3 | 2019 | 134 | 0.160 |
Why?
| | Dexamethasone | 1 | 2001 | 329 | 0.160 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 230 | 0.160 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2018 | 44 | 0.160 |
Why?
| | Cysts | 1 | 2019 | 96 | 0.160 |
Why?
| | Bleomycin | 4 | 2022 | 218 | 0.160 |
Why?
| | Polymers | 1 | 2023 | 476 | 0.160 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 276 | 0.160 |
Why?
| | Guinea Pigs | 5 | 2005 | 159 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 80 | 0.150 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 457 | 0.150 |
Why?
| | Paraquat | 1 | 2018 | 13 | 0.150 |
Why?
| | Signal Transduction | 8 | 2022 | 4809 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2019 | 163 | 0.150 |
Why?
| | Herbicides | 1 | 2018 | 23 | 0.150 |
Why?
| | Colitis | 1 | 2020 | 226 | 0.150 |
Why?
| | Methacholine Chloride | 2 | 2015 | 48 | 0.150 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 22 | 0.140 |
Why?
| | Schistosoma | 1 | 2017 | 19 | 0.140 |
Why?
| | Mast Cells | 2 | 2021 | 115 | 0.140 |
Why?
| | Transgenes | 1 | 2018 | 180 | 0.140 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1642 | 0.140 |
Why?
| | Mucin-2 | 1 | 2016 | 3 | 0.140 |
Why?
| | Bacteria | 3 | 2020 | 767 | 0.140 |
Why?
| | Leukocytes | 2 | 2016 | 292 | 0.140 |
Why?
| | Carcinogenesis | 1 | 2018 | 186 | 0.140 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 132 | 0.140 |
Why?
| | Neurons | 2 | 2005 | 1365 | 0.140 |
Why?
| | Cytokines | 6 | 2021 | 1927 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2001 | 554 | 0.140 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 24 | 0.140 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 26 | 0.140 |
Why?
| | Bronchoconstriction | 2 | 2011 | 26 | 0.140 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 137 | 0.130 |
Why?
| | Glycosylation | 1 | 2016 | 133 | 0.130 |
Why?
| | Survival Analysis | 3 | 2018 | 1341 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 363 | 0.130 |
Why?
| | Neutrophils | 3 | 2017 | 1250 | 0.130 |
Why?
| | Thiocyanates | 1 | 2015 | 30 | 0.130 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 7 | 0.130 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 6 | 0.130 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 42 | 0.130 |
Why?
| | Mutation | 5 | 2018 | 3520 | 0.130 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 3 | 0.130 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.120 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 5 | 0.120 |
Why?
| | Models, Biological | 2 | 2013 | 1753 | 0.120 |
Why?
| | Polysaccharides | 1 | 2014 | 88 | 0.120 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1376 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2806 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2017 | 319 | 0.110 |
Why?
| | Microbiota | 1 | 2021 | 683 | 0.110 |
Why?
| | Species Specificity | 1 | 2015 | 592 | 0.110 |
Why?
| | Ear, Middle | 1 | 2013 | 95 | 0.110 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.110 |
Why?
| | Bed Rest | 1 | 2013 | 16 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2913 | 0.110 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 459 | 0.110 |
Why?
| | Smoking | 2 | 2018 | 1635 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 410 | 0.110 |
Why?
| | Genes, Essential | 1 | 2012 | 22 | 0.100 |
Why?
| | Semiconductors | 1 | 2012 | 36 | 0.100 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 34 | 0.100 |
Why?
| | Muscle Development | 1 | 2013 | 103 | 0.100 |
Why?
| | Crystallization | 1 | 2012 | 150 | 0.100 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 213 | 0.100 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 53 | 0.100 |
Why?
| | Polymerization | 1 | 2012 | 129 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1008 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2018 | 840 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2013 | 238 | 0.100 |
Why?
| | Base Sequence | 3 | 2017 | 2207 | 0.100 |
Why?
| | Sarcopenia | 1 | 2013 | 76 | 0.100 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.100 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.100 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 11 | 0.100 |
Why?
| | Genes, ras | 2 | 2009 | 99 | 0.100 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 14 | 0.100 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 21 | 0.090 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 67 | 0.090 |
Why?
| | Integrases | 2 | 2010 | 125 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2013 | 338 | 0.090 |
Why?
| | Sepsis | 1 | 2017 | 563 | 0.090 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 53 | 0.090 |
Why?
| | Th1 Cells | 1 | 2011 | 137 | 0.090 |
Why?
| | Phosphines | 1 | 2010 | 29 | 0.090 |
Why?
| | Goblet Cells | 2 | 2020 | 17 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 985 | 0.090 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 400 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 727 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3047 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 545 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 951 | 0.080 |
Why?
| | Apoptosis | 3 | 2014 | 2553 | 0.080 |
Why?
| | Middle Aged | 7 | 2021 | 29112 | 0.080 |
Why?
| | Latex | 1 | 2009 | 13 | 0.080 |
Why?
| | Curcumin | 1 | 2009 | 34 | 0.080 |
Why?
| | Pentanes | 1 | 2009 | 11 | 0.080 |
Why?
| | Hemiterpenes | 1 | 2009 | 13 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2013 | 478 | 0.080 |
Why?
| | Elastomers | 1 | 2009 | 25 | 0.080 |
Why?
| | Emulsions | 1 | 2009 | 47 | 0.080 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 581 | 0.080 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 201 | 0.080 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.080 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 97 | 0.080 |
Why?
| | Cell Extracts | 1 | 2008 | 17 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2000 | 276 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 532 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2017 | 2753 | 0.080 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 184 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 2135 | 0.080 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 41 | 0.070 |
Why?
| | Gait | 1 | 2010 | 258 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2008 | 176 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2007 | 141 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 147 | 0.070 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 304 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2010 | 710 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 211 | 0.070 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 400 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 222 | 0.070 |
Why?
| | Walking | 1 | 2010 | 431 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 379 | 0.070 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 317 | 0.070 |
Why?
| | Chemokines, CC | 1 | 2005 | 29 | 0.070 |
Why?
| | Time Factors | 3 | 2011 | 6780 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 46 | 0.070 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 476 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1559 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1880 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 332 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 19411 | 0.060 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 2 | 0.060 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 306 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 577 | 0.060 |
Why?
| | Pneumonia | 3 | 2017 | 610 | 0.060 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 238 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 563 | 0.060 |
Why?
| | Aerosols | 3 | 2010 | 224 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 895 | 0.060 |
Why?
| | Adult | 3 | 2021 | 33167 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1568 | 0.060 |
Why?
| | Transcriptome | 2 | 2019 | 801 | 0.060 |
Why?
| | Trachea | 2 | 2020 | 238 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2098 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 334 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3152 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1706 | 0.050 |
Why?
| | Ions | 1 | 2023 | 70 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 289 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 3153 | 0.050 |
Why?
| | Diffusion | 1 | 2023 | 129 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2926 | 0.050 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 497 | 0.050 |
Why?
| | ErbB Receptors | 2 | 2018 | 574 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2021 | 68 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 176 | 0.050 |
Why?
| | Antibodies | 2 | 2000 | 396 | 0.050 |
Why?
| | Quinuclidines | 1 | 2000 | 4 | 0.050 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 10 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 841 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 71 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 100 | 0.040 |
Why?
| | Protein Binding | 2 | 2017 | 2014 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 95 | 0.040 |
Why?
| | Haemophilus Infections | 2 | 2010 | 33 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 201 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 2000 | 229 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 635 | 0.040 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.040 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.040 |
Why?
| | Cross Protection | 1 | 2019 | 4 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 14 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2014 | 2333 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 162 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 785 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 411 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 3 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 6 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 63 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 36 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 171 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 170 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 392 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 236 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 294 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 32 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1080 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 73 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 420 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 2009 | 0.040 |
Why?
| | Sputum | 1 | 2020 | 293 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 12 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 211 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 337 | 0.040 |
Why?
| | Larva | 1 | 2019 | 220 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 524 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 144 | 0.040 |
Why?
| | Immunologic Techniques | 1 | 1997 | 40 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1366 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 629 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 10 | 0.040 |
Why?
| | Body Composition | 2 | 2013 | 679 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 161 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 232 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 760 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 47 | 0.040 |
Why?
| | Biopsy | 1 | 2001 | 1093 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 89 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 125 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 138 | 0.040 |
Why?
| | Thermodynamics | 2 | 2009 | 391 | 0.040 |
Why?
| | Acetylcholine | 1 | 1997 | 212 | 0.040 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 12 | 0.030 |
Why?
| | Aged | 5 | 2015 | 20859 | 0.030 |
Why?
| | NF-kappa B | 2 | 2012 | 681 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 795 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 5 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 5 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 282 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 26 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 54 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3326 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 38 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 14 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 60 | 0.030 |
Why?
| | Child | 3 | 2021 | 20014 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 232 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2026 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 584 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 49 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 195 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 293 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 1010 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9938 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 523 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 112 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1248 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2014 | 286 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 328 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 870 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 667 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 4159 | 0.030 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 9 | 0.030 |
Why?
| | Whole Body Imaging | 1 | 2013 | 25 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1042 | 0.030 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 5 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 516 | 0.030 |
Why?
| | E-Box Elements | 1 | 2012 | 6 | 0.030 |
Why?
| | Ligands | 1 | 2014 | 574 | 0.030 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 29 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 143 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 134 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2012 | 147 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 238 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 2012 | 207 | 0.030 |
Why?
| | Cell Separation | 1 | 2013 | 299 | 0.030 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 15 | 0.020 |
Why?
| | Arthropod Proteins | 1 | 2011 | 4 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 419 | 0.020 |
Why?
| | Cecum | 1 | 2011 | 38 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 224 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 353 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 362 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 32 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 61 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 456 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 837 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 350 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 137 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 743 | 0.020 |
Why?
| | Habits | 1 | 2010 | 40 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 923 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 288 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2539 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 970 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1233 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3616 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 330 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1530 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 279 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1960 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 38 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1108 | 0.020 |
Why?
| | Speech | 1 | 2010 | 82 | 0.020 |
Why?
| | Survival | 1 | 2009 | 40 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 191 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 366 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 207 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 185 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 345 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 236 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 121 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 903 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1210 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1725 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 94 | 0.020 |
Why?
| | Leg | 1 | 2010 | 238 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 83 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 11 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 117 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 146 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 21 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 124 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 189 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 83 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 749 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 620 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 274 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 476 | 0.020 |
Why?
| | Exons | 1 | 2008 | 316 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 301 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 181 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 830 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 808 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1799 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 207 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 56 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1081 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 8 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 22 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 371 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 354 | 0.020 |
Why?
| | Body Weight | 1 | 2010 | 959 | 0.020 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 25 | 0.020 |
Why?
| | Motor Activity | 1 | 2010 | 689 | 0.020 |
Why?
| | Models, Genetic | 1 | 2008 | 607 | 0.020 |
Why?
| | Alleles | 1 | 2008 | 865 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1684 | 0.020 |
Why?
| | History, 20th Century | 1 | 2006 | 290 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 658 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1403 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 5456 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 742 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5517 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1198 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1196 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 11384 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2577 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1089 | 0.010 |
Why?
| | Infant | 1 | 2015 | 8625 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 3 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 7 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 10 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 16 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 34 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 39 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 29 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6936 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 84 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 5922 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|